Mimedx (MDXG) Inventory (2010 - 2026)

Mimedx (MDXG) has 17 years of Inventory data on file, last reported at $26.2 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 8.97% year-over-year to $26.2 million; the trailing twelve-month figure through Mar 2026 stood at $26.2 million (up 8.97% YoY), and the FY2025 full-year result was $25.3 million, up 6.44% from the prior year.
• Inventory climbed to $26.2 million in Q1 2026, from $25.3 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $26.5 million in Q3 2025 to a low of $13.2 million in Q1 2022.
• A 5-year average of $20.6 million and a median of $23.8 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 66.84% in 2024 and dropped 1.57% in 2025, its largest moves.
• Tracing MDXG's Inventory over 5 years: stood at $13.2 million in 2022, then soared by 59.46% to $21.0 million in 2023, then gained by 13.25% to $23.8 million in 2024, then advanced by 6.44% to $25.3 million in 2025, then advanced by 3.5% to $26.2 million in 2026.
• Business Quant data shows MDXG's Inventory at $26.2 million in Q1 2026, $25.3 million in Q4 2025, and $26.5 million in Q3 2025.